Technical Analysis for ELEV - Elevation Oncology, Inc.

Grade Last Price % Change Price Change
F 7.89 1.02% 0.08
ELEV closed up 1.02 percent on Monday, October 25, 2021, on 9 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical ELEV trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Fell Below 20 DMA Bearish 1.02%
Crossed Above 20 DMA Bullish -1.50%
Pocket Pivot Bullish Swing Setup -1.50%
Hammer Candlestick Bullish 2.47%
Lizard Bullish Bullish Day Trade Setup 2.47%
Older End-of-Day Signals for ELEV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 20 DMA about 17 hours ago
Rose Above 10 DMA about 17 hours ago
20 DMA Support 4 days ago
10 DMA Support 4 days ago
Down 3% 4 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically-defined patient populations in the United States. Its lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. The company was incorporated in 2019 and is based in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Clinical Medicine Life Sciences Pharmaceutical Industry Immunology Health Sciences Pharmacy Treatment Of Cancer Monoclonal Antibody Advanced Solid Tumors

Is ELEV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.22
52 Week Low 7.38
Average Volume 46,865
200-Day Moving Average 0.00
50-Day Moving Average 9.45
20-Day Moving Average 7.84
10-Day Moving Average 7.84
Average True Range 0.54
ADX 13.59
+DI 20.05
-DI 13.44
Chandelier Exit (Long, 3 ATRs) 6.85
Chandelier Exit (Short, 3 ATRs) 9.11
Upper Bollinger Bands 8.20
Lower Bollinger Band 7.47
Percent B (%b) 0.57
BandWidth 9.33
MACD Line -0.36
MACD Signal Line -0.48
MACD Histogram 0.1198
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.09
Resistance 3 (R3) 8.08 8.02 8.05
Resistance 2 (R2) 8.02 7.97 8.02 8.04
Resistance 1 (R1) 7.95 7.94 7.99 7.96 8.03
Pivot Point 7.89 7.89 7.90 7.89 7.89
Support 1 (S1) 7.82 7.84 7.86 7.83 7.75
Support 2 (S2) 7.76 7.81 7.76 7.74
Support 3 (S3) 7.69 7.76 7.73
Support 4 (S4) 7.70